ILMN : Analysis & Opinions

  1. Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst ...

    December 16, 2014
    On Dec 10, 2014, we issued an updated research report on Illumina Inc. (ILMN).
  2. Meet The 5 Companies Loving Obamacare

    November 4, 2014
    The Affordable Care Act (ACA) implemented many measures at the beginning of 2014. Amid these changes, stocks responded accordingly. ...
  3. Big Swings in Biotech Short Interest

    October 13, 2014
    Biotechs continue to prove volatile this year. While Gilead Sciences, Inc. (NASDAQ: VRTX). Other leading biotechs and emerging ...
  4. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  5. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  6. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  7. Pricing Still A Long-Term Risk, But Illumina Continues To Build ...

    August 15, 2013
    Pricing Still A Long-Term Risk, But Illumina Continues To Build A Sequencing Fortress Between the disruptions created by ...
  8. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  9. Thermo Steps Up And Seals A Deal For Life Technologies

    April 19, 2013
    Speculation has been all over the place for an M&A with LifeTech, but the final announcement is consistent with my expectations.
  10. Has Roche Said "Nein" To Illumina's Asking Price Once More?

    January 7, 2013
    Roche may have walked away from Illumina for good.
  11. Agilent's Grim Guidance Obscures Long-Term Value

    November 20, 2012
    Agilent's guidance points to another tough year.
  12. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally. ...
  13. Agilent Seeing Tougher Conditions, But Still A Quality Pick

    August 17, 2012
    Agilent's end markets have weakened, but the company looks well-positioned for the long term.
  14. Is There Enough Growth To Really Push Life Technologies?

    June 29, 2012
    Life Technologies isn't the growth stock people think it is, but at the right price it's a good holding.
  15. Medicine Gets Personalized

    June 28, 2012
    With our population continuing to age and grow, innovation in the healthcare sector will need to move just as fast. One such ...
  16. Neogen Is Almost Cheap

    December 30, 2011
    Neogen has to do more to validate this price.
  17. Will Qiagen's Restructuring Address The Real Problems?

    November 30, 2011
    Will Qiagen's Restructuring Address The Real Problems?
  18. 5 Oversold Stocks To Watch

    October 19, 2011
    Let's take a look at a few stocks that have recently entered oversold territory because these could be candidates for a short-term ...
  19. Affymetrix's Downward Spiral Continues

    July 7, 2011
    Affymetrix continues to flounder with unexciting technology.
  20. Illumina Lights Up Again

    April 29, 2011
    Illumina is a torrid grower, and growth investors seem to be willing to pay any price.
  21. Thermo Fisher Pays A High Price For Quality

    December 15, 2010
    Thermo Fisher makes a very reasonable purchase but pays a price to do so.
  22. The Stock-Split Portfolio

    December 6, 2010
    Many investors debate the merits of a stock split, but the bottom line doesn't lie. Find out how companies who split their ...
  23. A Fistfull Of Life Sciences

    October 29, 2010
    The life sciences field is showing encouraging growth and mostly reasonable valuations.
  24. The Next-Gen Sequencing Pot Keeps Bubbling

    August 23, 2010
    Last week saw two major developments in one of the fastest-growing arenas of life science.
  25. Sequencing Wars - The Third Generation

    June 10, 2010
    Life sciences companies are gearing up for a battle that could decide hundreds of millions of dollars in revenue and the ...
  26. Small Med-Tech Names You Should Know

    April 15, 2010
    These three med-tech names aren't well-known by most investors, but they should be.
  27. Stock Splits Worth A Look

    May 11, 2009
    What does the decline in stock splits mean for investors?
  28. Affymetrix Misses Revenue Again And Again

    October 16, 2008
    Affymetrix missed revenue for the third consecutive quarter and blamed weak sales on a weak market - something competitors ...
  29. Getting Technical With Biotech

    July 11, 2008
    Watch as a blend of technical and fundamental analysis reveals hidden gems in this unpredictable sector.
Trading Center